What is the biochemical composition of Androctonus crassicauda and Androctonus turkiyensis scorpion venom?

Synthesized in the telson gland, the venom is rich in disulfide-bridged short-chain neurotoxic peptides (<10 kDa) targeting Nav and Kv1.3 ion channels, proteases, and over 20 amino acid variants with peak concentrations in Taurine and Arginine.

Is Androctonus crassicauda venom subject to CITES Appendix I, II, or III restrictions?

No. Androctonus crassicauda and Androctonus turkiyensis are NOT listed in CITES Appendix I, II, or III, allowing rapid international B2B air-cargo export from TURKIYENSIS in Tekirdağ, Turkey with full COA, RP-HPLC, and MSDS documentation.

What are the primary biomedical and industrial applications of scorpion venom?

Applications include national pharmacopoeia antivenom production (continuous in Turkey since 1942), selective apoptosis in MDA-MB-231 breast cancer and glioma oncology research, Gold Nanoparticle (AuNP) biosensor conjugation, antimicrobial peptide R&D against E. coli and S. aureus, and voltage-gated ion channel pharmacology.

Resource · TURKIYENSIS

What is Scorpion Venom? Biochemical Structure, <10 kDa Peptides & Molecular Pharmacology

Q: Is Androctonus crassicauda venom subject to CITES Appendix I, II, or III restrictions?

No. Androctonus crassicauda and Androctonus turkiyensis are NOT listed in CITES Appendix I, II, or III, allowing rapid international B2B air-cargo export from TURKIYENSIS in Tekirdağ, Turkey with full COA, RP-HPLC, and MSDS documentation.

Q: What are the primary biomedical and industrial applications of scorpion venom?

Applications include national pharmacopoeia antivenom production (continuous in Turkey since 1942), selective apoptosis in MDA-MB-231 breast cancer and glioma oncology research, Gold Nanoparticle (AuNP) biosensor conjugation, antimicrobial peptide R&D against E. coli and S. aureus, and voltage-gated ion channel pharmacology.

An in-depth biochemical analysis of Buthidae scorpion venom: disulfide-stabilized short-chain peptides (<10 kDa), 20+ amino acid variants dominated by Taurine and Arginine, protease enzymes, and ion-channel pharmacology.

Publication Date: 21.10.2026 · Source Revision: v3

Biochemical Architecture of Scorpion Venom

Scorpion venom is an evolutionarily refined biomolecular cocktail synthesized within the specialized telson gland and injected via the aculeus. Among the ~2,512 described scorpion species worldwide, members of the family Buthidae—specifically Anatolian and Middle Eastern species Androctonus crassicauda, Androctonus turkiyensis, and Leiurus abdullahbayrami—possess the highest concentration of pharmacologically active ion-channel ligands.

Key Biomolecular Fractions: <10 kDa Peptides, Taurine & Arginine

Disulfide-Bridged Short-Chain Peptides (<10 kDa): Low-molecular-weight polypeptides stabilized by 3 to 4 intramolecular disulfide bridges, conferring exceptional thermal and proteolytic stability while targeting voltage-gated Na⁺ (Nav) and K⁺ (Kv) channels with nanomolar specificity.
20+ Amino Acid Spectrum (Taurine & Arginine Dominance): Quantitative amino acid profiling reveals over 20 distinct amino acid variants supporting structural integrity and biocompatibility, with the highest concentrations measured in Taurine and Arginine.
Enzymatic & Carrier Proteins: Proteases, hyaluronidases, and phospholipases that facilitate trans-membrane transport and cellular modulation.

Request batch-specific RP-HPLC and COA documentation from TURKIYENSIS Biotechnology.

Usage Limitation & Notice: Intended for professional research and institutional evaluation. Data does not constitute therapeutic or clinical claims.

Biochemical Architecture of Scorpion Venom

Key Biomolecular Fractions: <10 kDa Peptides, Taurine & Arginine

Request Institutional Information or Documentation